Anthony DeSantis, M.D.
Metabolism, Endocrinology and Nutrition
Clinical Associate Professor of Medicine
Dr. DeSantis specializes in Endocrinology focusing on type 1 and type 2 diabetes, adrenal problems, metabolic bone disease, pituitary problems and thyroid problems. He is the Course Chair for the Second year medical students basic science curriculum, Hormones & Nutrients.
DeSantis, A. Update in Endocrinology: Evidence Published in 2010. Ann Intern Med, 2011;154:684-89.
Wallia, Amisha, DeSantis, A, et al Glycemic Control by a Glucose Management Service and Infection Rates following Liver Transplantation. Endocrine Practice, in press.
Odegaard, P, DeSantis, A. Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity Targets and Therapy,2009;1-10.
DeSantis, A. Molitch, M. Intensive insulin management of inpatient hyperglycemia: the time for implementation is now. Acta Biomed 2008;79:5-8
Liao, P., DeSantis, A., Schmeltz, L., Schmidt, K.,Oshea-Mahler, E.,Victor, S.,Molitch, M., Insulin Resistance Following Cardiothoracic Surgery with and without a Preoperative Diagnosis of Type 2 Diabetes During treatment with Intravenous Insulin Therapy for Postoperative Hyperglycemia. Journal of Diabetes and Its Complications 22 (2008) 229-34.
Schmeltz, L., DeSantis, A. Thiyagarajan, V.; Molitch, M., et al Reduction of Surgical Mortality and Morbidity in Diabetic Patients undergoing Cardiac Surgery with a Combined Intravenous and Subcutaneous Insulin Glucose Management Strategy. Diabetes Care 2007;30:823-828.
Schmeltz, L., DeSantis, A.,Schmidt, K., Mahler, E., Molitch, M. Conversion of Intravenously Administered Insulin Infusions to Subcutaneously Administered Insulin Glargine in Patients with Hyperglycemia. Endoc Practice 2006;12:641-50.
DeSantis, A., Schmeltz, L., Schmidt, K., Mahler, E., Molitch, M, et al. Inpatient Hyperglycemia Management: The Northwestern Experience. Endoc Pract 2006;12:491-505.
Mintzer, S, Boppana, P, Toguri, J & DeSantis, A Vitamin D Levels and Bone Turnover in Epilepsy Patients Taking Carbamazepine or Oxcarbazepine.. Epilepsia 2006;47 (3), 510-515
Edwards BJ. Bunta AD, Madison LD, DeSantis A, Ramsey-Goldman R, Taft L, Wilson C, Moinfar M. An Osteoporosis and Fracture Intervention Program (OFIP) increases diagnosis and treatment for osteoporosis for patients with minimal trauma fractures The Joint Commission Journal on Quality and Patient Safety 2005: 31:267-274
DeSantis, A, Buchman, A., Current and Emerging Therapies for Osteoporosis. Expert Opin. Pharmacother.3:835-843:2002